AICAR has been used clinically to treat and protect against cardiac ischemic injury
Cas No: 2627-69-2
Appearance: white powder
Aicar (AICA-Riboside) strongly inhibits the transcription of PPAR&alpha and the coactivation of PPAR&alpha. In adipocyte studies it has been shown to antagonize lipolysis induced by isoprenaline and has been suggested for use in kinase cascade research. Additionally, research indicates that AICAR blocks the differentiation of 3T3-L1 (sc-2243) adipocytes.
AICAR has been used clinically to treat and protect against cardiac ischemic injury.
Conforms to structure
Conforms to MW
Complies with enterprise standard
Add: Zhuhai city,Guangdong Province, China